RecruitingNCT00178594

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders

Evaluation of Hemostasis in Bleeding and Thrombotic Disorders Using the Roteg Analyzer and the Thrombin Generation Assay


Sponsor

The University of Texas Health Science Center, Houston

Enrollment

1,000 participants

Start Date

Oct 1, 2002

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.


Eligibility

Min Age: 1 DayMax Age: 98 Years

Plain Language Summary

Simplified for easier understanding

This study evaluates how blood clots and bleeds in people with inherited or acquired bleeding and clotting disorders. Researchers use blood tests and other procedures to better understand how these conditions affect the body's ability to manage blood flow and clotting. You may be eligible if: - You are between 1 day and 98 years of age - You have a congenital (inherited) or acquired bleeding or clotting disorder - You have provided informed consent (or a guardian has) - You have adequate venous access for blood draws You may NOT be eligible if: - You have poor venous access that prevents sample collection Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(2)

The Univerisity of Texas Health Science Center at Houston

Houston, Texas, United States

UT Physicians Women's Center-Texas Medical Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT00178594